An empirical study of voluntary research and development disclosures of biotechnology firms listed on NASDAQ
This empirical study attempts to establish the relationship between a firm's voluntary disclosures on research and development and its size, growth options, leverage and its independent auditor's reputation. Based on the results of this study, it was established that for biotechnology firm...
Saved in:
Main Authors: | Gan, Peck Yen, Low, Calvin Sin Chye, Chim, Wai Kay |
---|---|
Other Authors: | Tan, Pearl Hock Neo |
Format: | Theses and Dissertations |
Language: | English |
Published: |
2008
|
Subjects: | |
Online Access: | http://hdl.handle.net/10356/7271 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Similar Items
-
Determinants of R&D Disclosures of Nasdaq-Listed Biotechnology Firms
by: TAN, Pearl Hock Neo, et al.
Published: (2005) -
Voluntary disclosure in the biotechnology industry
by: Pan, Grace Meiyun, et al.
Published: (2008) -
Firm characteristics and their impact on voluntary disclosure for Singapore and Hong Kong listed companies.
by: Ng, Sharon Woan Yng., et al.
Published: (2008) -
Voluntary disclosure of listed companies in Singapore.
by: Chang, Mun Ling., et al.
Published: (2008) -
Voluntary corporate disclosure by companies listed on the Singapore Exchange (SGX).
by: Chong, Yew Tuck., et al.
Published: (2008)